July 09, 2026 — RNews

#lymphoma — Thursday, July 09, 2026 (1 items)

top new

0

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial. (linkinghub.elsevier.com)

Davids MS … Wierda WG The Lancet 2026-07-09

#leukemia #lymphoma #clinical trial #immunotherapy #pharmacotherapy